TACE COST
GLOBAL COMPARISON
TACE costs differ by a factor of 4–10× between Western countries and leading academic centres in China and India — a difference driven entirely by labour economics and institutional overhead, not clinical quality or equipment.
analyticsAt a Glance
- check_circleSingle TACE session: USD 40,000–80,000 (US) vs USD 5,000–18,000 (China/India) — same procedure, 4–10× cost difference
- check_circleMost HCC patients require 3–6 TACE sessions — total treatment course cost multiplies accordingly
- check_circleThe cost gap reflects physician salary structures and hospital overhead, not equipment, drug, or technical quality differences
- check_circleCancerFax provides itemised written cost estimates before any travel commitment is made
Why TACE Costs Vary So Dramatically Between Countries
TACE uses the same equipment (fluoroscopy suite, microcatheters, embolic microspheres), the same drugs (doxorubicin, DC Bead or Lipiodol), and requires the same clinical skills regardless of where in the world it is performed. What varies between a USD 60,000 US TACE and a USD 12,000 Chinese TACE is not the procedure — it is the cost of the humans performing it and the institution housing them.
“The drug-eluting bead is the same in Shanghai as in Houston. The interventional radiologist has the same training. The fluoroscopy machine is the same brand. What changes at the border is what the hospital charges for the room, the physician, the nurse, and the administrator.”
US Cost Structure: Why USD 60,000
A US interventional radiologist performing TACE bills USD 8,000–15,000 in physician fees alone. Hospital facility fees for the interventional radiology suite add USD 5,000–10,000 per day. ICU or step-down monitoring, pharmacy charges for embolic agents and doxorubicin, anaesthesiology, nursing, and radiology reads are all separately itemised. Institutional liability insurance, regulatory compliance overhead, and profit margin complete the picture.
China and India Cost Structure: Why USD 10,000–15,000
Physician salaries in China and India are 8–15× lower than in the US by international comparison. Hospital infrastructure at academic medical centres is government-subsidised in China. Drug costs for doxorubicin, DC Bead, and Lipiodol are lower due to domestic procurement. High procedure volumes reduce per-procedure fixed costs. None of these factors reduce clinical quality — they reflect labour economics, not care standards.
TACE Cost by Country: All-Inclusive Single Session
The following estimates reflect the total all-inclusive cost of a single TACE session — including physician fees, hospital/facility fees, drugs, sedation, monitoring, and 1–3 night hospital stay.
Single TACE Session: All-Inclusive Hospital Cost (Moderate Complexity)
cTACE or DEB-TACE; single session; Child-Pugh A; 1–3 nodule HCC; 1–3 day hospital stay. HAIC port placement adds USD 2,000–4,000.
- India (top private hospital)USD 5,000–14,000
- China (Tier 3A academic centre)USD 8,000–18,000
- UK / Germany (private or self-pay)USD 18,000–40,000
- United States (academic centre)USD 40,000–80,000
HAIC (Hepatic Arterial Infusion Chemotherapy) Cost: China vs US
HAIC port placement + first cycle FOLFOX infusion; China includes HAP device; US includes device, facility, pharmacy
- HAIC (1 cycle + port): ChinaUSD 3,500–7,000
- HAIC (1 cycle + port): IndiaUSD 3,000–6,000
- HAIC (1 cycle + port): United StatesUSD 20,000–50,000+
What Is Included in TACE Cost Quotes: Country Comparison
Always obtain an itemised written estimate — cost quotes differ significantly in what they include versus bill separately.
| Cost Item | China / India (Typically Included) | USA / Western Europe |
|---|---|---|
| Physician / IR fee | Bundled into procedural cost | Separately billed; USD 8,000–15,000 physician fee in US |
| Fluoroscopy suite / facility | Included in procedure room fee | Separate facility fee; USD 5,000–10,000/day |
| Sedation / anaesthesia | Included | Separately billed; USD 2,000–4,000 |
| Embolic agents (DC Bead, Lipiodol, gelfoam) | Included | Pharmacy charge; DC Bead USD 1,500–3,000 separately |
| Chemotherapy drug (doxorubicin, cisplatin) | Included | Pharmacy charge; varies |
| 1–3 night hospital stay | Included in total quote at most centres | USD 2,000–5,000/day ward; USD 4,000–10,000/day ICU — separately billed |
| Post-procedure blood tests (LFTs, AFP) | Usually included | Billed as separate lab orders |
| Follow-up imaging (MRI at 4–6 weeks) | Not included — outpatient | Not included — USD 800–2,500 for contrast MRI |
| Medical interpreter (China) | CancerFax provides — not in hospital cost | N/A |
| International travel and hotel | Never included | Never included |
Budgeting for a Complete TACE Treatment Course
Most HCC patients receive 3–6 TACE sessions over 12–24 months. Realistic total treatment course budgets differ significantly from single-session quotes.
China: Total Treatment Course Budget (3 Sessions)
Three TACE sessions at USD 8,000–18,000 each = USD 24,000–54,000 in procedure costs. Add return flights per visit (USD 700–2,000 depending on origin), accommodation near hospital (USD 50–150/night × 7 nights per visit), and CancerFax coordination (included at no patient cost). Total all-in for 3 visits to China: approximately USD 30,000–65,000. Compared to 3 sessions in the US (USD 120,000–240,000+), the savings are USD 90,000–180,000.
India: Total Treatment Course Budget (3 Sessions)
Three TACE sessions at USD 5,000–14,000 each = USD 15,000–42,000. For Gulf and South Asian patients with short flight times, total trip cost adds only USD 300–800 per visit for flights and USD 40–100/night accommodation. Total all-in: approximately USD 20,000–50,000 for 3 visits. The lowest total-cost option for patients from South Asia, the Gulf, and East Africa.
TACE Cost: Key Reference Numbers
Summary figures for patients comparing TACE access globally.
- 4–10×US-to-China/India cost ratio for TACEThe same procedure by an equivalently trained interventional radiologist, using the same equipment and drugs, costs 4–10× less in China or India than in the United States.
- USD 0CancerFax patient coordination feeCancerFax does not charge patients for case review, eligibility assessment, centre matching, interpreter coordination, or ongoing follow-up management.
- 3–6Typical number of TACE sessions in a complete treatment courseMost BCLC B HCC patients receive 3–6 sessions over 12–24 months — single-session cost quotes should always be multiplied by realistic session estimates for total budget planning.
- 20%Contingency recommended above base estimate for complicationsLiver abscess, prolonged hospital stay, or additional sessions add to base costs — a 20% contingency buffer above the base estimate is recommended.
More from the TACE Resource Library
Continue exploring TACE access, centres, and navigation.
- Zhongshan Hospital Shanghai: One of the World's Leading TACE Centres
- TACE in India: Centres, Costs, and Access
- Accessing TACE Through CancerFax: Patient Navigation Guide
- Questions to Ask Before and During TACE Treatment
- TACE Patient Selection: BCLC Staging and Child-Pugh Score
- TACE Therapy — Complete Treatment Guide
Frequently Asked Questions
Common questions from patients comparing TACE costs internationally.
About TACE Cost
Will my insurance cover TACE in China or India?
Most national health insurance systems (NHS, Medicare/Medicaid, standard GCC insurance) do not cover treatments performed abroad. Some international private health insurance policies and employer-sponsored global health plans include cross-border cancer treatment with prior authorisation. CancerFax can provide the clinical documentation — including the treating centre's qualifications, the procedure plan, and cost itemisation — needed to support a pre-authorisation request to your insurer. Even if insurance does not apply, the out-of-pocket cost in China or India is often lower than the co-pay or deductible for the same treatment in a Western healthcare system.
Are there hidden costs not included in the initial quote from a Chinese or Indian hospital?
There can be — which is why CancerFax always obtains a fully itemised written estimate before any patient travels. Common additional costs that generic hospital quotes may not include: complications requiring additional intervention (abscess drainage, prolonged ICU stay); supplementary drug costs if combination therapy is added during the procedure; follow-up imaging (contrast MRI at 4–6 weeks is almost always billed separately); and medical interpreter costs (included in CancerFax's coordination service). For HAIC, the port placement procedure is sometimes quoted separately from the first HAIC cycle. Request line-by-line itemisation, not a single bundled figure, from any centre before committing to travel.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Get an Itemised TACE Cost Estimate
CancerFax provides written itemised cost estimates from vetted TACE centres in China and India — covering all procedural, hospital, and monitoring costs — before any travel commitment is made. No surprise costs.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.